
Inbal Zelig developed robust data analysis and reporting features for the Ultimagen/ugbio-utils repository, focusing on bioinformatics workflows and reproducible pipelines. Over three months, Inbal delivered a centralized report generation utility that standardized notebook execution and HTML rendering across multiple modules, and introduced optional data visualizations such as barcode rank plots for single-cell quality control. The work emphasized maintainability and reliability through expanded unit testing, code linting with Ruff, and Docker-based development environments. Using Python, Docker, and GitHub Actions, Inbal improved developer onboarding, streamlined CI/CD processes, and ensured consistent, validated outputs for omics data analysis and reporting pipelines.

January 2025: Delivered a centralized Core Generic Report Generation Utility enabling consistent notebook execution, HTML rendering, and styling across modules (ppmseq, single_cell, SRSNV, methylation), added MRD Reports Script with dedicated entry point and unit tests, and improved the development workflow with updated devcontainer, pre-commit hooks, and documentation. Also updated dependencies and added test resources to support robust reporting.
January 2025: Delivered a centralized Core Generic Report Generation Utility enabling consistent notebook execution, HTML rendering, and styling across modules (ppmseq, single_cell, SRSNV, methylation), added MRD Reports Script with dedicated entry point and unit tests, and improved the development workflow with updated devcontainer, pre-commit hooks, and documentation. Also updated dependencies and added test resources to support robust reporting.
November 2024 highlights for Ultimagen/ugbio-utils: Delivered stronger test coverage for the single-cell module and testing infrastructure; hardened code quality with Ruff and pre-commit tooling; enhanced developer experience via Docker/devcontainer improvements; updated dependencies and CI/packaging to support omics builds; expanded documentation and tooling guidance for omics workflows; and realigned project configuration to reflect current structure. Business value: higher reliability in omics pipelines, faster iteration cycles, reproducible builds, easier onboarding, and reduced risk in production workflows.
November 2024 highlights for Ultimagen/ugbio-utils: Delivered stronger test coverage for the single-cell module and testing infrastructure; hardened code quality with Ruff and pre-commit tooling; enhanced developer experience via Docker/devcontainer improvements; updated dependencies and CI/packaging to support omics builds; expanded documentation and tooling guidance for omics workflows; and realigned project configuration to reflect current structure. Business value: higher reliability in omics pipelines, faster iteration cycles, reproducible builds, easier onboarding, and reduced risk in production workflows.
Month: 2024-10 — Focused on delivering reliable, business-value features for Ultimagen/ugbio-utils and strengthening data integrity and test coverage. Key outcomes include a new optional barcode rank plot for the Single-Cell QC Report, robustness improvements in data handling and warning suppression, and expanded unit tests for compare modules, enhancing reproducibility and confidence in dashboards and analyses.
Month: 2024-10 — Focused on delivering reliable, business-value features for Ultimagen/ugbio-utils and strengthening data integrity and test coverage. Key outcomes include a new optional barcode rank plot for the Single-Cell QC Report, robustness improvements in data handling and warning suppression, and expanded unit tests for compare modules, enhancing reproducibility and confidence in dashboards and analyses.
Overview of all repositories you've contributed to across your timeline